Search MEDP
Medpace Holdings, Inc.
Nasdaq · CIK 1668397
Last close599.47
Daily change+1.39 (0.23%)
10 Years gain+1863.54%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
MEDP · STANDARD
SIC 8731 · Services-Commercial Physical & Biological Research · Fiscal year end 1231
Fundamental
82.4Momentum
51.9Acceleration
71.1Confidence
86.0Annual Revenue11
Quarterly Revenue43
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth21.8 / 25
Quality17.8 / 25
Capital Efficiency20.0 / 20
Balance Sheet9.3 / 15
Shareholder Economics9.8 / 10
Forward Indicators3.7 / 5
Signals
Operating leverageOperating margin improved by 0.3726 percentage points.
ROIC expansionROIC improved by 88.7658 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 8.469%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM25.63%OK
Revenue CAGR 3Y20.12%OK
Gross Marginn/aMISSING
Operating Margin20.79%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC167.16%OK
Incremental Operating Margin 3Y23.63%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-8.47%OK
SBC / Revenue0.8%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $2.53B | n/a | $534.94M | $713.22M | $681.87M | n/a | 21.14% | 26.95% | 753.29% | 29.53M |
| 2025 FY Dec 31, 2024 | $2.11B | n/a | $446.87M | $608.82M | $572.27M | n/a | 21.19% | 27.13% | 161.71% | 32.01M |
| 2025 FY Dec 31, 2023 | $1.89B | n/a | $336.83M | $433.37M | $396.73M | n/a | 17.86% | 21.04% | 78.65% | 31.84M |
| 2024 FY Dec 31, 2022 | $1.46B | n/a | $278.70M | $388.05M | $351.17M | n/a | 19.09% | 24.05% | 53.74% | 33.67M |
| 2023 FY Dec 31, 2021 | $1.14B | n/a | $198.62M | $263.33M | $235.06M | n/a | 17.39% | 20.58% | 35.1% | 37.7M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.68B | sum latest 4 fiscal quarters Revenue | OK | 0001668397-26-000025, 0001668397-25-000110 |
| Revenue Growth TTM | 25.63% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001668397-26-000025, 0001668397-25-000110 |
| Revenue CAGR 3Y | 20.12% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001668397-26-000006 |
| Revenue CAGR 5Y | 22.27% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001668397-26-000006 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | 27.92% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001668397-26-000025, 0001668397-25-000110 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Margin | 20.79% | Operating Income / Revenue | OK | 0001668397-26-000025, 0001668397-25-000110 |
| ROIC | 167.16% | NOPAT / Average Invested Capital | OK | 0001668397-26-000025, 0001668397-25-000110 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001668397-26-000025 |
| Current Ratio | 0.73x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 0.8% | SBC / Revenue | OK | 0001668397-26-000025, 0001668397-25-000110 |
| Revenue per Diluted Share | $93.76 | Revenue / Diluted Shares | OK | 0001668397-26-000025, 0001668397-25-000110 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | 0001668397-26-000025, 0001668397-25-000110 |